Hostname: page-component-586b7cd67f-l7hp2 Total loading time: 0 Render date: 2024-11-30T20:09:58.655Z Has data issue: false hasContentIssue false
  • English
  • Français

Inappropriate Use of Antifungal Medications in a Tertiary Care Center in Thailand: A Prospective Study

Published online by Cambridge University Press:  02 January 2015

Apisada Sutepvarnon ,
Anucha Apisarnthanarak ,
Bernard Camins ,
Kristin Mondy  and
Victoria J. Fraser
Apisada Sutepvarnon
Affiliation:
Division of Infectious Diseases and Infection Control, Faculty of Medicine, Thammasart University Hospital, Pratumthani, Thailand
Anucha Apisarnthanarak*
Affiliation:
Division of Infectious Diseases and Infection Control, Faculty of Medicine, Thammasart University Hospital, Pratumthani, Thailand
Bernard Camins
Affiliation:
Division of Infectious Diseases, Washington University School of Medicine, Saint Louis, Missouri
Kristin Mondy
Affiliation:
Division of Infectious Diseases, Washington University School of Medicine, Saint Louis, Missouri
Victoria J. Fraser
Affiliation:
Division of Infectious Diseases, Washington University School of Medicine, Saint Louis, Missouri
*
Division of Infectious Diseases, Faculty of Medicine, Thammasart University Hospital, Pratumthani, Thailand12120 ([email protected])
Get access Rights & Permissions [Opens in a new window]

Abstract

The incidence and factors associated with inappropriate use of antifungal medications were studied in a Thai tertiary care center. The incidence of inappropriate antifungal use was 74% (in 42 of 57 patients). Isolation of Candida species from urine (P = .004) was a risk factor, whereas receipt of an infectious diseases consultation (P = .004) was protective.

Type
Concise Communications
Information
Infection Control & Hospital Epidemiology , Volume 29 , Issue 4 , April 2008 , pp. 370 - 373
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Loeffler, J, Stevens, DA. Antifungal drug resistance. Clin Infect Dis 2003;36(suppl 1):S31–41.Google Scholar
2.NCCLS. Methods for antifungal disk diffusion susceptibility testing of yeasts: Approved guideline. NCCLS document. Wayne, PA: NCCLS, 2004:M44–A.Google Scholar
3.Mandel, GL, Bennett, JE, Dolin, R, eds. Mandeli, Douglas and Bennett's Principles and Practice of Infectious Diseases. 6th ed. New York, NY: Churchill Livingstone; 2005.Google Scholar
4.Kunin, CM, Tupasi, T, Craig, WA. Use of antibiotics: a brief exposition of the problem and some tentative solutions. Ann Intern Med 1973;79:555–560.Google Scholar
5.Warren, JW, Abrutyn, E, Hebel, JR. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis. Clin Infect Dis 1999;29:745–758.CrossRefGoogle ScholarPubMed
6.Lundstrom, T, Sobel, J. Nosocomial candiduria: a review. Clin Infect Dis 2001;32:1602–1607.Google Scholar
7.Gutierrez, F, Patrick, GW, Cohen, J. Antimicrobial practice: an audit of the use of antifungal agents. J Antimicrob Chemother 1996;37:175–185.CrossRefGoogle ScholarPubMed
8.Apisarnthanarak, A, Danchaivijitr, S, Bailey, TC, Fraser, VJ. Inappropriate antibiotic use in a tertiary care center in Thailand: an incidence study and review of experience in Thailand. Infect Control Hosp Epidemiol 2006;27:416–420.Google Scholar
9.Classen, DC, Burk, JP, Wenzel, RP. Infectious diseases consultation: impact on outcomes for hospitalized patients and results of a preliminary study. Clin Infect Dis 1997;24:468–470.Google Scholar
10.Petrak, RM, Sexton, DJ, Butera, ML, et al.The value of an infectious diseases specialist. Clin Infect Dis 2003;36:1013–1017.CrossRefGoogle ScholarPubMed